BSEDecipher Labs LtdLowNeutral
Announced Tue, 30 Sept · 16:47 IST

Outcome of the Annual General Meeting

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Decipher Labs Limited (formerly Combat Drugs Limited) held its 39th Annual General Meeting on September 30, 2025, at 11:00 a.m. via video conference, concluding at 11:16 a.m. with 39 members present. Five resolutions were tabled — three ordinary and two special — including adoption of FY25 audited financial statements, re-appointment of Mr. Janaki Ram Ajjarapu (retiring by rotation), appointment of Secretarial Auditors for five years, and re-appointment of two Independent Directors (Mr. Venkateswara Rao Gudipudi and Mrs. Lakshmi Vijaya Nimmala). All resolutions were passed unanimously with 100% votes in favour: 2,57,725 total valid votes cast by 96 members (94 via remote e-voting and 2 at the AGM), with zero votes against and no invalid votes. Promoter and Non-Executive Director Mr. Janaki Ram Ajjarapu could not attend due to a technical glitch.

Likely market impact

This is a routine procedural compliance filing with all resolutions passing unanimously and zero dissent, so no negative impact is expected on the stock. Shareholders raised queries on financials, future outlook, and dividend declaration, but no material decisions were disclosed.